A new migraine medication, meloxicam and rizatriptan (Symbravo), was just approved by the U.S. Food and Drug Administration (FDA) that may bring relief to people who haven’t had good results ...

Drugs that can prevent or relieve migraine attacks are only effective for some people. Research is starting to untangle the ...

For children and teens living with migraine, there may be a new preventive treatment, according to a preliminary study. Researchers found the drug zonisamide, which has been used to treat seizures, ...

Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults. Per the company, Symbravo, a ...

as they suggest we have a good medication option that helps to prevent both migraines and strokes,” she noted in the press release. The new study will be presented this week at the American Stroke ...

However, high drug prices and the complex process of gaining approval from regulatory bodies may restrain the market to some extent. Overall, the migraine drugs market is poised for sustained growth ...

Another study found that 500mg of magnesium ... therapy to sodium valproate on the prevention of chronic migraine with aura. Medicine (Baltimore). 2017;96(27):e7477. doi:10.1097/MD.

When you’re dealing with migraine pain or feel one coming on, taking medicines to ease the pain may help. You might try medicines you can buy at the store, such as ibuprofen or aspirin with ...

Per the company, Symbravo, a novel, oral medicine, offers a multi-mechanistic approach to treating migraine. It targets multiple pathways underlying a migraine attack. AXSM expects to launch ...

A headache lasting more than 72 hours must be addressed in the emergency room or with a doctor. Here's why it happens and the ...

The American College of Physicians (ACP) has developed new recommendations to prevent ... use monotherapy with the antiseizure medication topiramate. Migraine is characterized by recurrent ...